Celebrating a fruitful weekend where I received my Hong Kong College of Physicians fellowship, the Gold Medal for best thesis, and a Distinguished paper award Also congratulations to @loeymak, @JimmyLaiCT and Michael Cheung for their great papers! @hkudeptmedicine @hkumed

We studied HBV integration patterns in different disease phases. Integrations associated with HCC were observed regardless of hepatitis activity, viremia level, and HBsAg positivity Another reason to expand NUC treatment indication? @WK_Seto @jamesyyfung @loeymak @hkumed

We studied Days At Home (DAH) reflecting the disease time burden. Immunotherapy gives HCC patients more DAH than tyrosine kinase inhibitor treatment. https://t.co/JQHQOcM1Dk Congratulations to @RexWHHui @MattChungHKU @CarlosWongHKU @Ian_HKU @hkumed @JHEP_Reports

Celebrating my PhD graduation with my supervisor Professor MF Yuen, and @WK_Seto @IvanHung2 @loeymak Happy to wrap up this chapter and looking forward to more exciting science ahead @hkumed @hkudeptmedicine

HKUMed researchers have started clinical trials exploring a pioneering gene-related therapy for chronic hepatitis B infection, potentially allowing patients to stop long-term medication. For more: https://t.co/r0FsNVHAgQ

A new article in Hepatology International examines emerging therapies for HBsAg seroclearance, with a focus on innovative novel combination strategies that hold promise for functional cure. This comprehensive review offers critical insights for clinicians and researchers alike.

Our work has been awarded Gold Medal – Best Original Research by Trainees by The Hong Kong Academy of Medicine for the 2nd straight year🥇🥇 Grateful for 2024, and looking forward to a fruitful 2025! Prof MF Yuen, @WK_Seto, @jamesyyfung , @loeymak @hkumed @hkudeptmedicine

Our paper described the longitudinal profile of blood levels of HBV pregenomic RNA in CHB 🦠patients treated with long term NUC 💊now in press @CMH_journal https://t.co/WpJdkpw3ZL Clinical parameters eg age, gender, PAGE-B score and HBeAg can influence pgRNA levels #mfyuen

The era of #AI and #XAI for liver diseases has come! #HKASLD #ASM2024 #HCC #BigData #EHRs @tung_hung @RexWHHui

Hepatology team from @hkudeptmedicine attending The Liver Meeting @AASLDtweets @AASLDFoundation @WK_Seto @jamesyyfung @RexWHHui

Our paper on ALT/qHBsAg after stopping ETV has been awarded the Young Investigator Medal by the Hong Kong College of Physicians Thankful as always to Professor MF Yuen, @WK_Seto @jamesyyfung @loeymak for their tremendous support Full paper https://t.co/iaSVZpOuOV

#GUTAbstract by Mao et al on "Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study" via https://t.co/uA32k1nwpr Paper: https://t.co/vpBwqtmcvM @WK_Seto @CheungKaShingM2 @hkumed @HKUniversity

Our very own associate TAE @RexWHHui and team describe an interesting case of a sub-diaphragmatic air-fluid level 👇 https://t.co/UJTNV2gWQD @sheiybani @MohsenSubhani @VivekGoodoory @DunnePdj @DrJMKennedy @RMBeattie50

Professor Yuen Man Fung developed an interest in hepatitis B early in his career thanks to the prevalence of the disease in Hong Kong. Almost three decades on, his breakthrough research is now guiding potential treatments. For more: https://t.co/pfoZe4jZL5

Check out two recently published articles on the advances in Hepaititis B and Hepatitis D treatments! https://t.co/CaKWknSBPa https://t.co/mSAOxHgmPT

🆕Article in press❕ ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B Read it here👉 https://t.co/KZJXSjhhSw #LiverTwitter

Researchers from HKUMed have launched a pilot programme to provide rapid screening for hepatitis C followed by treatment for people in custody in Stanley Prison. @loeymak @hkudeptmedicine For more: https://t.co/bi291k5j3V

A small step in Hong Kong 🇭🇰 for microelimination of hepatitis C infection @hkumed @hkudeptmedicine

Proud to share results from our AI model: Recurr-NET, for predicting HCC recurrence after surgery Thankful to the team @WK_Seto Prof MF Yuen @jamesyyfung @loeymak, and also to @AASLDFoundation for selecting it as a top HCC abstract🏆 @hkumed @hkudeptmedicine @AASLDtweets

The Liver Team from @hkumed is attending and presenting at #TLM2023 in Boston 🇺🇸🍁